Replimune Group, Inc. (REPL)
1.95
+0.25
(+14.71%)
USD |
NASDAQ |
Apr 14, 16:00
1.91
-0.04
(-2.05%)
After-Hours: 06:49
Replimune Group Price : 1.95 for April 14, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ANI Pharmaceuticals, Inc. | 78.29 |
| Phathom Pharmaceuticals, Inc. | 12.67 |
| REGENXBIO, Inc. | 9.30 |
| Bristol Myers Squibb Co. | 58.08 |
| Organon & Co. | 8.70 |
Price Related Metrics
| PEG Ratio | -0.039 |
| Price to Book Value | 0.7648 |
| Earnings Yield | -183.7% |
| Market Cap | 161.02M |
| PEGY Ratio | -0.039 |